Clinical Trial Highlights

• A Genome-Wide SNP Association Study Identifies Novel Risk Loci for Rheumatoid Arthritis in Swedish EIRA Study
• Tocilizumab, a Novel Monoclonal Antibody Targeting IL-6 Signaling, Significantly Reduces Disease Activity in Patients with Rheumatoid Arthritis
• Breast Feeding Reduces the Risk of Rheumatoid Arthritis
• Rheumatoid Arthritis Disease Activity is Significantly Reduced during Pregnancy
• Strontium Ranelate Reduces the Risk of Vertebral Fracture in Postmenopausal Women with Severe Osteoporosis
• Alcohol Consumption is Associated with Decreased Risks for Developing Rheumatoid Arthritis: Results from the Swedish EIRA Study
• Induction of Remission in Early Rheumatoid Arthritis with Infliximab and Methotrexate Therapy
• The RANKL Inhibitor Denosumab Reduces Progression of the Total Sharp Score and Bone Erosions in Patients with Rheumatoid Arthritis
• Combination TNF-Inhibitor-MTX Therapy is Superior to MTX Monotherapy in Reducing the Risk of Acute Myocardial Infarction in Patients with Rheumatoid Arthritis
• Non-Vertebral Fracture Reduction with High- vs Low-Dose Ibandronate